215 related articles for article (PubMed ID: 8901651)
1. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.
Juhan-Vague I; Pyke SD; Alessi MC; Jespersen J; Haverkate F; Thompson SG
Circulation; 1996 Nov; 94(9):2057-63. PubMed ID: 8901651
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group.
Juhan-Vague I; Thompson SG; Jespersen J
Arterioscler Thromb; 1993 Dec; 13(12):1865-73. PubMed ID: 8241109
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
5. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm.
Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Björkander I; Eriksson SV; Forslund L; Wiman B
Circulation; 1997 May; 95(10):2380-6. PubMed ID: 9170400
[TBL] [Abstract][Full Text] [Related]
7. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
8. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction.
Eriksson-Berg M; Egberg N; Eksborg S; Schenck-Gustafsson K
Thromb Res; 2002 Mar; 105(6):481-6. PubMed ID: 12091046
[TBL] [Abstract][Full Text] [Related]
9. Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men.
Wannamethee SG; Whincup PH; Shaper AG; Rumley A; Lennon L; Lowe GD
J Thromb Haemost; 2009 Oct; 7(10):1605-11. PubMed ID: 19682232
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death.
Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
Int J Cardiol; 2002 Oct; 85(2-3):277-83. PubMed ID: 12208595
[TBL] [Abstract][Full Text] [Related]
12. Short-term prognostic value of lipid measurements in patients with angina pectoris. The ECAT Angina Pectoris Study Group: European Concerted Action on Thrombosis and Disabilities.
Bolibar I; von Eckardstein A; Assmann G; Thompson S;
Thromb Haemost; 2000 Dec; 84(6):955-60. PubMed ID: 11154140
[TBL] [Abstract][Full Text] [Related]
13. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
Tataru MC; Heinrich J; Junker R; Schulte H; von Eckardstein A; Assmann G; Koehler E
Eur Heart J; 1999 Oct; 20(20):1493-502. PubMed ID: 10493848
[TBL] [Abstract][Full Text] [Related]
14. Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina.
Bogaty P; Robitaille NM; Solymoss S; Boyer L; Auger D; Labbé L; Simard S; Rail J; Genest J; Turgeon J
Am Heart J; 1998 Nov; 136(5):884-93. PubMed ID: 9812085
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls.
Held C; Hjemdahl P; Rehnqvist N; Wallén NH; Forslund L; Björkander I; Angelin B; Wiman B
J Intern Med; 1997 Jan; 241(1):59-69. PubMed ID: 9042095
[TBL] [Abstract][Full Text] [Related]
16. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
Cushman M; Lemaitre RN; Kuller LH; Psaty BM; Macy EM; Sharrett AR; Tracy RP
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):493-8. PubMed ID: 10073948
[TBL] [Abstract][Full Text] [Related]
18. In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.
Eržen B; Šabovič M
Heart Vessels; 2013 Sep; 28(5):570-7. PubMed ID: 23001714
[TBL] [Abstract][Full Text] [Related]
19. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes.
Passoni F; Morelli B; Seveso G; Lazzati L; Beria G; Del Rosso G; D'Urbano M; Cafiero F; Mariani G; De Servi S
Ital Heart J; 2002 Jan; 3(1):28-33. PubMed ID: 11899586
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of hemostatic factors for sudden death in patients with stable angina pectoris.
Benchimol D; Dartigues JF; Benchimol H; Drouillet F; Lauribe P; Marazanof M; Couffinhal T; Bonnet J
Am J Cardiol; 1995 Aug; 76(4):241-4. PubMed ID: 7618616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
